Company
Arvinas
Arvinas has 8 drugs tracked on RxWires: 1 in Phase 2, 4 in Phase 1/2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ARV-471 | Phase 2 | Breast Cancer |
| ARV-6723 | Phase 1/2 | Advanced Solid Tumor |
| ARV-806 | Phase 1/2 | KRAS G12D Mutation |
| ARV-110 | Phase 1/2 | Prostate Cancer Metastatic |
| Vepdegestrant | Phase 1/2 | Breast Cancer |
| Bavdegalutamide | Phase 1 | Prostate Cancer Metastatic |
| ARV-393 | Phase 1 | Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) |
| ARV-471 in combination with Everolimus | Phase 1 | Breast Cancer |
Latest
- arvinas filed 8-K
- arvinas filed 8-K
- arvinas filed 8-K
- arvinas filed 8-K
- Licensing / Collaboration Deal: arvinas
Follow Arvinas on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.